170 related articles for article (PubMed ID: 1375306)
1. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum.
Perry KW; Fuller RW
Life Sci; 1992; 50(22):1683-90. PubMed ID: 1375306
[TBL] [Abstract][Full Text] [Related]
2. Effect of fluoxetine pretreatment on the neurochemical changes induced by amfonelic acid combined with spiperone in rats.
Fuller RW; Snoddy HD
J Pharm Pharmacol; 1986 Oct; 38(10):776-7. PubMed ID: 2432213
[TBL] [Abstract][Full Text] [Related]
3. Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain.
Caccia S; Fracasso C; Garattini S; Guiso G; Sarati S
Neuropharmacology; 1992 Apr; 31(4):343-7. PubMed ID: 1381817
[TBL] [Abstract][Full Text] [Related]
4. Monoamine metabolism in the striatum of the rat brain during drug infusion into the nucleus accumbens.
Saul'skaya NB
Neurosci Behav Physiol; 1997; 27(6):728-33. PubMed ID: 9406229
[TBL] [Abstract][Full Text] [Related]
5. Isoflurane anesthesia inhibits clozapine- and risperidone-induced dopamine release and anesthesia-induced changes in dopamine metabolism was modified by fluoxetine in the rat striatum: an in vivo microdialysis study.
Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T; Mimuro S; Sato S
Neurochem Int; 2008 Feb; 52(3):384-91. PubMed ID: 17719143
[TBL] [Abstract][Full Text] [Related]
6. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis.
Hernandez L; Auerbach S; Hoebel BG
Life Sci; 1988; 42(18):1713-23. PubMed ID: 2452334
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats.
Mendelsohn FA; Jenkins TA; Berkovic SF
Brain Res; 1993 Jun; 613(2):221-9. PubMed ID: 7514480
[TBL] [Abstract][Full Text] [Related]
8. Effects of tamoxifen on striatal dopamine and 5-hydroxytryptamine release in freely moving male rats: an in-vivo microdialysis investigation.
Chaurasia CS; Chen CE; Rubin J; Dewey SL
J Pharm Pharmacol; 1998 Dec; 50(12):1377-85. PubMed ID: 10052853
[TBL] [Abstract][Full Text] [Related]
9. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
10. Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites.
Phebus LA; Clemens JA
Life Sci; 1989; 44(19):1335-42. PubMed ID: 2469926
[TBL] [Abstract][Full Text] [Related]
11. Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo.
Miyake H; Chiueh CC
Eur J Pharmacol; 1989 Jul; 166(1):49-55. PubMed ID: 2478372
[TBL] [Abstract][Full Text] [Related]
12. Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis.
Damsma G; Boisvert DP; Mudrick LA; Wenkstern D; Fibiger HC
J Neurochem; 1990 Mar; 54(3):801-8. PubMed ID: 2303812
[TBL] [Abstract][Full Text] [Related]
13. In vivo neurochemical evaluation of striatal serotonergic hyperinnervation in rats depleted of dopamine at infancy.
Jackson D; Abercrombie ED
J Neurochem; 1992 Mar; 58(3):890-7. PubMed ID: 1371152
[TBL] [Abstract][Full Text] [Related]
14. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
Gerhardt GA; Maloney RE
Brain Res; 1999 Jan; 816(1):68-77. PubMed ID: 9878690
[TBL] [Abstract][Full Text] [Related]
15. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues.
Nash JF; Nichols DE
Eur J Pharmacol; 1991 Jul; 200(1):53-8. PubMed ID: 1722755
[TBL] [Abstract][Full Text] [Related]
16. Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine.
Peinado J; Hameg A; Garay RP; Bayle F; Nuss P; Dib M
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):134-9. PubMed ID: 12595954
[TBL] [Abstract][Full Text] [Related]
17. Dynamic characteristics of dopamine, norepinephrine and serotonin metabolism in axonal endings of the rat hypothalamus and striatum during hypoxia: a study using HPLC with electrochemical detection.
Saligaut C; Chretien P; Daoust M; Moore N; Boismare F
Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):343-9. PubMed ID: 2426539
[TBL] [Abstract][Full Text] [Related]
18. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study.
Cumming P; Brown E; Damsma G; Fibiger H
J Neurochem; 1992 Nov; 59(5):1905-14. PubMed ID: 1383428
[TBL] [Abstract][Full Text] [Related]
19. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo.
Santiago M; Machado A; Cano J
Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats.
Perry KW; Fuller RW
J Neural Transm (Vienna); 1997; 104(8-9):953-66. PubMed ID: 9451727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
